Reclassification is here - it's right around the corner.
Overall, rescheduling ain't gonna do much. It will classify marijuana as a drug that has
potential for abuse, while still being acknowledged for its medicinal benefits.
The kicker though is the tax and banking implications.
1. Reclassifying cannabis to Schedule III will move it out of the purview of IRC Sec. 280E
2. In the states where marijuana is legal, these cannabis companies can deduct their ordinary business expenses for purposes of their state income tax.
3. All or most of MSOS's holdings will have a better tax advantage = more money in their
pockets...
4. Although safebanking is still needed - I guarentee you that bank servicing of cannabis companies will move foward with reclassification
5. Compound this with lower interest rates in the next 6 months. Small cap rotation.
6. Last 4-5 buy signals outta 10 saw 30-50% gains
6. ONE HUGE CAVEAT = The elections and what direction Trump will go.
Just some thoughts. Good luck ya'll